ACT-based Physical Activity Program for Depression
Trial Summary
What is the purpose of this trial?
The goal of the proposed project is to conduct a feasibility clinical trial comparing group-based acceptance and commitment therapy for physical activity, (ACT; ACTivity) to a time- and attention-matched standard PA intervention (i.e., PA education, goal-setting, and self-monitoring) plus relaxation training comparison condition (Relaxercise) among 60 low-active adults (ages 18-65) with elevated depressive symptoms. Participants will be randomized to treatment condition, followed for 6 months, including the 8-week treatment. Participants will be randomized 1:1 to treatment condition, followed for 6 months, including the 8-week treatment, and receive a 6-month YMCA membership to equate access to PA facilities.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment ACTivity, Relaxercise for depression?
Is the ACT-based Physical Activity Program for Depression safe for humans?
How does the ACT-based Physical Activity Program for Depression differ from other treatments for depression?
The ACT-based Physical Activity Program for Depression is unique because it combines physical activity with Acceptance and Commitment Therapy (ACT), which focuses on accepting thoughts and feelings rather than fighting them. This approach is different from traditional treatments like medication or standard psychotherapy, as it emphasizes both physical movement and psychological flexibility to help reduce depressive symptoms.28101112
Research Team
Da M Wil, Ph.D.
Principal Investigator
Brown University School of Public Health
Eligibility Criteria
This trial is for adults aged 18-65 with depressive symptoms who are not very active (less than 60 minutes of moderate exercise per week). They must be able to attend weekly virtual sessions and have a stable Rhode Island address. Exclusions include extreme BMI, conditions limiting physical activity, active suicidal thoughts, participation in other related studies, non-English speakers, and regular mindfulness practitioners.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either ACT-based physical activity promotion or Relaxercise for 8 weeks
Follow-up
Participants are monitored for changes in depression symptoms and physical activity over 6 months
Treatment Details
Interventions
- ACTivity
- Relaxercise
Find a Clinic Near You
Who Is Running the Clinical Trial?
Brown University
Lead Sponsor
National Center for Complementary and Integrative Health (NIH)
Collaborator
National Center for Complementary and Integrative Health (NCCIH)
Collaborator